A. Forgione

462 total citations
27 papers, 347 citations indexed

About

A. Forgione is a scholar working on Pharmacology, Pharmacology and Organic Chemistry. According to data from OpenAlex, A. Forgione has authored 27 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 7 papers in Pharmacology and 6 papers in Organic Chemistry. Recurrent topics in A. Forgione's work include Pharmacogenetics and Drug Metabolism (6 papers), Inflammatory mediators and NSAID effects (6 papers) and Analytical Chemistry and Chromatography (5 papers). A. Forgione is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Inflammatory mediators and NSAID effects (6 papers) and Analytical Chemistry and Chromatography (5 papers). A. Forgione collaborates with scholars based in Italy, Japan and Czechia. A. Forgione's co-authors include Luca Miele, Antonio Grieco, V. Vero, Walter Fratta, Marco Diana, Alfio Bertolini, R. Mancinelli, Gian Battista Azzena, V. Mandelli and Antonio Gasbarrini and has published in prestigious journals such as The Journal of Organic Chemistry, Journal of Chromatography A and Psychopharmacology.

In The Last Decade

A. Forgione

25 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Forgione Italy 12 74 70 60 58 55 27 347
Robert L. Roe United States 11 26 0.4× 138 2.0× 71 1.2× 114 2.0× 29 0.5× 19 592
Olle Lantto Sweden 15 39 0.5× 18 0.3× 32 0.5× 174 3.0× 123 2.2× 22 482
G. John Digregorio United States 12 21 0.3× 52 0.7× 61 1.0× 17 0.3× 24 0.4× 33 353
Lennart Meurling Sweden 13 19 0.3× 115 1.6× 25 0.4× 27 0.5× 32 0.6× 23 487
Jörgen Lehmann Sweden 10 30 0.4× 65 0.9× 69 1.1× 47 0.8× 20 0.4× 25 333
Charles A. Harrington United States 13 15 0.2× 91 1.3× 132 2.2× 31 0.5× 85 1.5× 26 632
M. Badian Germany 11 17 0.2× 112 1.6× 68 1.1× 63 1.1× 23 0.4× 24 397
Allan Stowell New Zealand 15 109 1.5× 41 0.6× 50 0.8× 16 0.3× 50 0.9× 24 550
Tillement Jp France 11 27 0.4× 66 0.9× 37 0.6× 14 0.2× 28 0.5× 72 381
Niclas Lunder Norway 7 43 0.6× 44 0.6× 29 0.5× 62 1.1× 20 0.4× 10 355

Countries citing papers authored by A. Forgione

Since Specialization
Citations

This map shows the geographic impact of A. Forgione's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Forgione with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Forgione more than expected).

Fields of papers citing papers by A. Forgione

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Forgione. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Forgione. The network helps show where A. Forgione may publish in the future.

Co-authorship network of co-authors of A. Forgione

This figure shows the co-authorship network connecting the top 25 collaborators of A. Forgione. A scholar is included among the top collaborators of A. Forgione based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Forgione. A. Forgione is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grieco, Antonio, Luca Miele, A. Forgione, et al.. (2008). Mild hepatitis at recommended doses of acetaminophen in patients with evidence of constitutionally enhanced cytochrome P450 system activity. Journal of Clinical Pharmacy and Therapeutics. 33(3). 315–320. 11 indexed citations
2.
Cainazzo, Maria Michela, et al.. (2005). Pharmacokinetics of a new extended-release nifedipine formulation following a single oral dose, in human volunteers.. PubMed. 31(3). 115–21. 7 indexed citations
3.
Cavazzuti, E., R Poggioli, A. Forgione, et al.. (1999). l -Sulpiride, at a low, non-neuroleptic dose, prevents conditioned fear stress-induced freezing behavior in rats. Psychopharmacology. 143(1). 20–23. 18 indexed citations
4.
Mancinelli, R., Gian Battista Azzena, Marco Diana, A. Forgione, & Walter Fratta. (1998). In vitro excitatory actions of corticotropin‐releasing factor on rat colonic motility. Journal of Autonomic Pharmacology. 18(6). 319–324. 39 indexed citations
5.
Vergoni, Anna Valeria, A. Forgione, & Alfio Bertolini. (1995). Chronic administration ofl-sulpiride at non-neuroleptic doses reduces the duration of immobility in experimental models of “depression-like” behavior. Psychopharmacology. 121(2). 279–281. 14 indexed citations
6.
Serra, Gino, A. Forgione, Paolo S. D’Aquila, et al.. (1990). Possible Mechanism of Antidepressant Effect of l-Sulpiride. Clinical Neuropharmacology. 13. S76–S83. 33 indexed citations
7.
Serra, Gino, Maria Collu, M.C. Martellotta, A. Forgione, & Walter Fratta. (1989). Effect of fipexide on passive avoidance behaviour in rats. Pharmacological Research. 21(5). 603–608. 1 indexed citations
8.
Furlanut, Mario, et al.. (1988). Pharmacokinetics of benperidol in volunteers after oral administration.. PubMed. 8(1). 13–6. 4 indexed citations
9.
Palatini, Pietro, et al.. (1988). Stereospecific disposition of flunoxaprofen enantiomers in human beings.. PubMed. 8(3). 161–7. 7 indexed citations
10.
Sacchi, C. A., et al.. (1988). Stereochemical pharmacokinetics of the 2-arylpropionic acid non-steroidal antiinflammatory drug flunoxaprofen in rats and in man.. PubMed. 38(8). 1170–5. 6 indexed citations
11.
Zanoboni-Muciaccia, W., et al.. (1987). Determination of flunoxaprofen enantiomers in biological fluids by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 415(1). 214–220. 12 indexed citations
12.
Zanoboni-Muciaccia, W., et al.. (1987). Determination of the non-steroidal anti-inflammatory drug flunoxaprofen, S(+)-2-(4-fluorophenyl)-α-methyl-5-benzoxazoleacetic acid, in blood and urine by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 413. 338–341. 5 indexed citations
13.
Furlanut, Mario, et al.. (1985). Absorption and disposition kinetics of flunoxaprofen and benoxaprofen in healthy volunteers.. PubMed. 5(3). 165–70. 9 indexed citations
14.
Forgione, A., et al.. (1983). Anti allergic agents 6. substituted 2 trans ethenyl 4 oxo 4h pyrido 1 2 a pyrimidine 7 carboxylic acids. 18(3). 227–232. 4 indexed citations
15.
Forgione, A., et al.. (1980). ChemInform Abstract: ANTIALLERGIC AGENTS. III. SUBSTITUTED TRANS‐2‐ETHENYL‐4‐OXO‐4H‐1‐BENZOPYRAN‐6‐CARBOXYLIC ACIDS. Chemischer Informationsdienst. 11(5). 11 indexed citations
16.
Perrone, Ettore, et al.. (1979). ChemInform Abstract: SYNTHESIS AND PHARMACOLOGICAL ACTIVITY OF SOME 5,6‐DIPHENYL‐PYRIDAZINES. Chemischer Informationsdienst. 10(26). 1 indexed citations
17.
18.
Moro, E., et al.. (1974). GLC Determination of Plasma Levels of Enantiomers of α-[4-(1-Oxo-2-isoindolinyl)phenyl]propionic Acid. Journal of Pharmaceutical Sciences. 63(7). 1072–1076. 19 indexed citations
19.
Franchi, G, et al.. (1973). A spectrophotometric method for the estimation of the carcinostatic agent 6-chrysenamine (E.O.R.T.C. II6) in biological fluids and tissues. European Journal of Cancer (1965). 9(8). 591–595. 3 indexed citations
20.
Forgione, A., P. Martelli, F. Marcucci, et al.. (1971). Gas—Liquid chromatography and mass spectrometry of various benzodiazepines. Journal of Chromatography A. 59(1). 163–168. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert L. Roe Breakdown of academic impact, for papers by Olle Lantto Breakdown of academic impact, for papers by G. John Digregorio Breakdown of academic impact, for papers by Lennart Meurling Breakdown of academic impact, for papers by Jörgen Lehmann Breakdown of academic impact, for papers by Charles A. Harrington Breakdown of academic impact, for papers by M. Badian Breakdown of academic impact, for papers by Allan Stowell Breakdown of academic impact, for papers by Tillement Jp Breakdown of academic impact, for papers by Niclas Lunder
Rankless by CCL
2026